Saudi Arabia
· Delayed Price · Currency is SAR Al-Razi Medical Company Statistics
Total Valuation
Al-Razi Medical Company has a market cap or net worth of SAR 64.68 million. The enterprise value is 73.21 million.
| Market Cap | 64.68M |
| Enterprise Value | 73.21M |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Al-Razi Medical Company has 1.52 million shares outstanding.
| Shares Outstanding | 1.52M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 66.77% |
| Owned by Institutions (%) | n/a |
| Float | 505,153 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.04 |
| PB Ratio | 2.89 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.54, with an EV/FCF ratio of -833.66.
| EV / Earnings | 815.49 |
| EV / Sales | 1.18 |
| EV / EBITDA | 16.54 |
| EV / EBIT | 119.95 |
| EV / FCF | -833.66 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.77 |
| Quick Ratio | 0.14 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | -105.14 |
| Interest Coverage | 1.16 |
Financial Efficiency
Return on equity (ROE) is 0.40% and return on invested capital (ROIC) is 1.20%.
| Return on Equity (ROE) | 0.40% |
| Return on Assets (ROA) | 0.84% |
| Return on Capital (ROIC) | 1.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.36 |
| Inventory Turnover | 2.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -28.86% |
| 50-Day Moving Average | 43.82 |
| 200-Day Moving Average | 50.35 |
| Relative Strength Index (RSI) | 44.21 |
| Average Volume (20 Days) | 1,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Al-Razi Medical Company had revenue of SAR 61.99 million and earned 89,777 in profits. Earnings per share was 0.06.
| Revenue | 61.99M |
| Gross Profit | 16.34M |
| Operating Income | 610,340 |
| Pretax Income | 438,203 |
| Net Income | 89,777 |
| EBITDA | 2.14M |
| EBIT | 610,340 |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 696,816 in cash and 9.23 million in debt, giving a net cash position of -8.54 million or -5.62 per share.
| Cash & Cash Equivalents | 696,816 |
| Total Debt | 9.23M |
| Net Cash | -8.54M |
| Net Cash Per Share | -5.62 |
| Equity (Book Value) | 22.38M |
| Book Value Per Share | 14.72 |
| Working Capital | 11.17M |
Cash Flow
In the last 12 months, operating cash flow was 6.06 million and capital expenditures -6.15 million, giving a free cash flow of -87,821.
| Operating Cash Flow | 6.06M |
| Capital Expenditures | -6.15M |
| Free Cash Flow | -87,821 |
| FCF Per Share | -0.06 |
Margins
Gross margin is 26.35%, with operating and profit margins of 0.98% and 0.14%.
| Gross Margin | 26.35% |
| Operating Margin | 0.98% |
| Pretax Margin | 0.71% |
| Profit Margin | 0.14% |
| EBITDA Margin | 3.45% |
| EBIT Margin | 0.98% |
| FCF Margin | -0.14% |
Dividends & Yields
This stock pays an annual dividend of 0.78, which amounts to a dividend yield of 1.83%.
| Dividend Per Share | 0.78 |
| Dividend Yield | 1.83% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 666.99% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.83% |
| Earnings Yield | 0.14% |
| FCF Yield | -0.14% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Al-Razi Medical Company has an Altman Z-Score of 4.04.
| Altman Z-Score | 4.04 |
| Piotroski F-Score | n/a |